Citation Impact
Citing Papers
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
2014
Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
2010
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Use of mass media campaigns to change health behaviour
2010 Standout
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
2009
From tumour heterogeneity to advances in precision treatment of colorectal cancer
2016
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
XM02, the first granulocyte colony-stimulating factor biosimilar, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with non-Hodgkin lymphoma receiving chemotherapy
2009
Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial
2007
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
2011
Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis
2008
Development of a new G-CSF product based on biosimilarity assessment
2009
Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy–Neutropenia (FACT-N)
2007
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
2007
Kinetics of Neutrophils in Mice Exposed to Radiation and/or Granulocyte Colony-Stimulating Factor Treatment
2013
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
2006
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain - results of the LEARN Study
2008
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Histological and molecular types of breast cancer: is there a unifying taxonomy?
2009
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
2017
Incidence of Febrile Neutropenia and Myelotoxicity of Chemotherapy: A Meta-Analysis of Biosimilar G-CSF Studies in Breast Cancer, Lung Cancer, and Non-Hodgkin’s Lymphoma
2009
Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?
2005
Polymer conjugates as anticancer nanomedicines
2006 Standout
Design considerations for tumour-targeted nanoparticles
2009 StandoutNobel
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Nanomedicine
2006
Canadian Supportive Care Recommendations for the Management of Neutropenia in Patients with Cancer
2008
Using Multigene Tests to Select Treatment for Early-Stage Breast Cancer
2013
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma
2007
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia
2003
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
Open-label, Randomized Study of Pegfilgrastim vs. Daily Filgrastim as an Adjunct to Chemotherapy in Elderly Patients with Non-Hodgkin's Lymphoma
2003
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials
2007
Current understanding of the human microbiome
2018 Standout
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
2010
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Gene-Expression Signatures in Breast Cancer
2009
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Tumor Microenvironment of Metastasis and Risk of Distant Metastasis of Breast Cancer
2014
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma
2006
TAILORx: Trial Assigning Individualized Options for Treatment (Rx)
2006
Client-Directed Interventions to Increase Community Demand for Breast, Cervical, and Colorectal Cancer Screening
2008
Organic Switches for Surfaces and Devices
2012 StandoutNobel
pH-Responsive mechanised nanoparticles gated by semirotaxanes
2009 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Serum Pegfilgrastim Concentrations During Recovery of Absolute Neutrophil Count in Patients with Cancer Receiving Pegfilgrastim After Chemotherapy
2007
Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy
2009
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory
2008
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
2006
Decision aids for people facing health treatment or screening decisions
2017 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Breast Cancer Treatment
2019 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Antiarrhythmic Drug Therapy for Atrial Fibrillation
2012
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Impact of Five Prophylactic Filgrastim Schedules on Hematologic Toxicity in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide
2005
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity.
2006
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Interventions That Increase Use of Adult Immunization and Cancer Screening Services
2002
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Prevention of Chemotherapy-Induced Febrile Neutropenia by Prophylactic Antibiotics Plus or Minus Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: A Dutch Randomized Phase III Study
2005
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
2016
Works of James Hackett being referenced
Optimized RNA extraction and RT-PCR assays provide successful molecular analysis on a wide variety of archival fixed tissues
2007
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
2006
Fixed-dose Pegfilgrastim is Safe and Allows Neutrophil Recovery in Patients with Non-Hodgkin's Lymphoma
2003
Bone Pain Associated with Once-Per-Cycle Pegfilgrastim Is Similar to Daily Filgrastim in Patients with Breast Cancer
2003
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine
2008
Collagen‐assisted healing of facial wounds after mohs surgery
1994
Filgrastim‐Mediated Neutrophil Recovery in Patients with Breast Cancer Treated with Docetaxel and Doxorubicin
2003
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer
2002
Impact of chemotherapy-induced neutropenia on quality of life: a prospective pilot investigation
2005
Biomarker discovery for colon cancer using a 761 gene RT-PCR assay
2007
Gene expression and breast cancer mortality in Northern California Kaiser Permanente Patients: A large population-based case control study
2005
Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma
2003
Are Shorter Courses of Filgrastim Prophylaxis Associated with Increased Risk of Hospitalization?
2006
Pap Smear Outreach: A Randomized Controlled Trial in an HMO
1997
A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
2003